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Abstract  22 
Background & aim: There is increasing evidence that the plasma concentration of vitamin 23 
D, carotenoids, zinc and selenium are associated with the magnitude of the systemic 24 
inflammatory response.  In order to examine whether other vitamins may be affected and 25 
whether red cell concentrations are less affected by systemic inflammation the aim of the 26 
present study was to examine the effect of the systemic inflammatory response on red cell 27 
measurements of vitamins B1, B2 and B6, and plasma concentration of vitamin C and E in a 28 
large cohort of patients referred for a nutritional screen.  29 
Methods: Patients referred for nutritional assessment of B1 (n=551), B2 (n=251), B6 30 
(n=313), ascorbic acid (n=494) and α-tocopherol (n=395) concentrations.  These vitamins 31 
were measured using routine laboratory methods. 32 
Results: The median concentrations of vitamin B1 grouped according to C-reactive protein 33 
concentrations ≤10, 11-80 and >80 mg/L were 543, 664 and 766 ng/g Hb respectively 34 
(p<0.001, 41% higher).  The median concentration of vitamin B1 grouped according to 35 
albumin concentrations ≥35, 25-34 and <25 g/l were 547, 664 and 701 ng/g Hb respectively 36 
(p<0.001, 28% higher).  The median concentrations of red cell vitamin B2 grouped according 37 
to CRP concentrations ≤10, 11-80 and >80 mg/L were 2.2, 2.3 and 2.4 nmol/g Hb 38 
respectively (p<0.001, 9% higher).  The median red cell concentrations of vitamin B2 39 
grouped according to albumin concentrations ≥35, 25-34 and <25 g/l were 2.1, 2.4 and 2.3 40 
nmol/g Hb respectively (p<0.001, 14% higher).  The median concentrations of red cell 41 
vitamin B6 grouped according to CRP concentrations ≤10, 11-80 and >80 mg/L were 534, 42 
548 and 767 pmol/g Hb respectively (p<0.001, 44% higher).  The median red cell 43 
concentrations of vitamin B6 grouped according to albumin concentrations ≥35, 25-34 and 44 
<25 g/l were 462, 644 and 840 pmol/g Hb respectively (p<0.001, 82% higher).   45 
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In contrast, the median plasma concentrations of ascorbic acid grouped according to CRP 46 
concentrations ≤10, 11-80 and >80 mg/L were 25.0, 15.0 and 6.0 µmol/l respectively (78% 47 
lower, p<0.001).  The median plasma concentrations of ascorbic acid grouped according to 48 
albumin concentrations ≥35, 25-34 and <25 g/l were 32.0, 13.0 and 5.0 µmol/l respectively 49 
(84% lower, p<0.001).  The median α-tocopherol/ cholesterol grouped according to CRP 50 
concentrations ≤10, 11-80 and >80 mg/L were 5.9, 4.6 and 2.1 umol/l respectively (64% 51 
lower, p<0.001).  The median α-tocopherol/cholesterol grouped according to albumin 52 
concentrations ≥35, 25-34 and <25 g/l were 6.0, 5.5 and 2.1 umol/l respectively (65% lower, 53 
p<0.001). 54 
Conclusion: Red cell concentrations of vitamins B1, B2 and B6 were not lower with an 55 
increasing systemic inflammatory response.  In contrast, plasma concentrations of vitamin C 56 
and E were lower.  Therefore, compared with plasma concentration, red cell concentrations of 57 
B1, B2 and B6 are likely to be more reliable measures of status in the presence of a systemic 58 
inflammatory response. 59 
Key words: Vitamin B1, B2; B6, ascorbic acid; α-tocopherol; C-reactive protein; albumin.60 
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1.1. Introduction 61 
There is increasing evidence that the plasma concentration of a variety of trace 62 
elements and vitamins are associated with the magnitude of the systemic inflammatory 63 
response [1-4].  There was significant lowering of plasma concentrations of vitamins A, B6, 64 
C, E, carotenoids and trace elements zinc and selenium associated with an elevated systemic 65 
inflammatory response, when adjusted for CRP concentrations alone [3].  Indeed, it was 66 
shown that as the severity of systemic inflammatory response increased, the proportion of 67 
results below the lower reference limit increased.  However, the variability of the association 68 
was considerable such that plasma α-tocopherol and ascorbic acid concentrations were not 69 
readily adjustable by CRP concentrations. Ghashut and co-workers (2013; 2014; 2016) have 70 
recently reported that plasma concentrations of fat soluble micronutrients such as 25 (OH) D, 71 
carotenoids, zinc and selenium may be confounded in the presence of a systemic 72 
inflammatory response with both CRP and albumin having an independent effect on plasma 73 
concentrations [5-7]. 74 
Therefore, it is of interest that red cell concentrations of some micronutrients appear 75 
to be less affected by the magnitude of the systemic inflammatory response [8;9].  Therefore, 76 
the aim of the present study was to examine the effect of the systemic inflammatory response, 77 
as evidenced by both CRP and albumin, on red cell measurements of vitamins B1, B2 and 78 
B6, and plasma measurements of vitamins C and E in a cohort of patients referred for 79 
nutritional screen.80 
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1.2 Patients and Methods 81 
1.2.1 Nutritional screen cohort red cell B1, B2, B6, C and E 82 
Consecutive heparin-treated whole-blood samples from individual patients that had 83 
red cell B1 (n=553), B2 (n=251) and B6 (n=313) measurements were examined.  These 84 
samples were received from hospitals throughout Scotland between January 2008 and March 85 
2013 for routine laboratory analysis.  Consecutive heparin-treated whole-blood samples from 86 
individual patients that had plasma vitamin C (n=494) and E (n=359) measurements were 87 
examined.  As a regional centre blood samples were sent for analysis if the patient was 88 
considered at nutritional risk and was often secondary to a number of disease states.  Only the 89 
patients who had both CRP and albumin measured with the vitamins were included.  90 
This investigation was conducted with the intent of developing local guidelines to aid 91 
in the interpretation of vitamin B1, B2, B6, C and E results. This was a large convenience 92 
retrospective sample that arose from an audit of patients who had a sample sent to a regional 93 
laboratory for a nutritional screen. The patient was anonymised and de-identified prior to 94 
analysis (Andrew Duncan and Donald C McMillan respectively). Approval for audit purposes 95 
was obtained from the local ethics committee of the North Glasgow NHS Trust.  96 
1.2.2. Analytical methods 97 
Vitamins B1, B2 and B6 were assessed by measuring TDP, FAD and PLP 98 
respectively in red blood cells.  Vitamins C and E were assessed by measuring ascorbic acid 99 
and α-tocopherol.  These were measured by HPLC using established routine laboratory 100 
methods previously described [1;10;11].  The inter assay precision was <10% for all analytes. 101 
C-reactive protein and albumin were measured using an automated analyzer 102 
(Architect; Abbot Diagnosis, Maidenhead, UK).  The limits of detection for albumin and C-103 
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reactive protein were 10g/L and 0.2 mg/L respectively.  The inter-assay CV was <6% for 104 
both analytes. 105 
1.2.3. Statistical analysis 106 
Data was presented in median and (range) value.  Correlations between variables in 107 
the convenience sample were carried out using the Spearman rank correlation.  The cohorts 108 
were divided into three groups according to CRP concentrations ≤10, 11-80 and >80 mg/L as 109 
previously described [12].  With each CRP group the concentration of individual vitamins 110 
B1, B2, B6, ascorbic acid and α-tocopherol/ cholesterol were grouped according to 3 111 
categories of albumin concentrations ≥ 35, 25-34,< 25 g/L as previously described [13].  A P- 112 
value < 0.05 was considered significant and the analysis of the data was carried out using 113 
SPSS software (version 19; SPSS Inc, Chicago, Ill).114 
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1.3. Results 115 
1.3.1 Nutritional screen cohorts 116 
The characteristics of the convenience sample for whole blood vitamin B1 (n=553) 117 
are shown in Table 1.  The majority were older than 50 years (median 54 years), male (50%) 118 
and had plasma albumin concentrations below the normal range whereas plasma CRP and 119 
whole blood vitamin B1 were in the normal range.  Whole blood vitamin B1 was 120 
significantly associated with CRP (rs= 0.290, p<0.001) and albumin (rs= -0.265, p<0.001).  121 
These relationships are shown in Figures 1a, 1b and 1c. 122 
The characteristics of the convenience sample for red cell vitamin B2 (n=251) are 123 
shown in Table 1.  The majority were older than 50 years (median 51 years), female (56%) 124 
and had plasma albumin were below the normal range and plasma CRP concentration and red 125 
cell vitamin B2 in the normal range.  Red cell vitamin B2 was significantly associated with 126 
CRP (rs= 0.189, p<0.01) and albumin (rs= 0.186, p<0.001).  These relationships are shown in 127 
Figures 2a, 2b and 2c. 128 
The characteristics of the convenience sample for red cell vitamin B6 (n=313) are 129 
shown in Table 1.  The majority were older than 50 years (median 51 years), female (60%) 130 
and had plasma albumin below the normal range and plasma CRP and red cell vitamin B6 in 131 
the normal range.  Red cell vitamin B6 was significantly associated with and albumin (rs=-132 
0.217, p<0.001).  These relationships are shown in Figures 3a, 3b and 3c. 133 
The characteristics of the convenience sample for ascorbic acid (n= 494) are also 134 
shown in Table 1.  The majority were older than 50 years (median 54 years), female (53%), 135 
and had plasma CRP and albumin and plasma ascorbic acid in the normal range.  Plasma 136 
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ascorbic acid was significantly associated with CRP (rs= -0.333, p<0.001) and albumin 137 
(rs=0.427, p<0.001).  These relationships are shown in Figures 4a, 4b and 4c. 138 
The characteristics of the convenience sample for α-tocopherol (n= 359) are shown in 139 
Table 1.  The majority were older than 50 years (median 52 years), male (52%) and had 140 
plasma albumin and cholesterol below the normal range, while plasma CRP and plasma α-141 
tocopherol were in the normal range.  Plasma α-tocopherol adjusted to cholesterol was 142 
significantly associated with CRP (rs=-0.424, p<0.001) and albumin (rs=0.531, p<0.001).  143 
These relationships are shown in Figures 5a, 5b and 5c. 144 
Nutritional screen cohort for whole blood vitamin B1 145 
The median concentrations of whole blood vitamin B1 (Table 2) grouped according 146 
to CRP concentrations ≤10, 11-80 and >80 mg/L were 543, 664 and 766 ng/g Hb respectively 147 
(p<0.001) with an overall elevation of 41%.  The median whole blood concentrations of 148 
vitamin B1 grouped according to albumin concentrations ≥35, 25-34 and <25 g/l were 547, 149 
664 and 701 ng/g Hb respectively (p<0.001) with an overall elevation of 28%. 150 
When albumin concentrations were ≥ 35 g/L, the median concentrations of whole 151 
blood vitamin B1 grouped according to CRP concentrations ≤10, 11-80 and >80 were 535, 152 
619 and 812 ng/g Hb respectively (p=0.003) with an overall elevation of 52%. When albumin 153 
concentrations were 25-34 g/L, the median concentrations of whole blood vitamin B1 154 
grouped according to CRP concentrations ≤10, 11-80 and >80 mg/L were 611, 693 and 776 155 
ng/g Hb respectively (p=0.011) with an overall elevation of 27%.  When albumin 156 
concentrations were < 25 g/L, the median concentrations of whole blood vitamin B1 grouped 157 
according to CRP concentrations ≤10, 11-80 and >80 mg/L were 574, 671 and 745 ng/g Hb 158 
respectively (p=0.118) with an overall elevation of 30%.  Median concentrations of vitamin 159 
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B1/ albumin x100 were significantly increased from 1450 to 2250 to 4030 respectively 160 
(p<0.001). 161 
1.3.2. Nutritional screen cohort for red cell vitamin B2 162 
The median concentrations of red cell vitamin B2 (Table 3) grouped according to 163 
CRP concentrations ≤10, 11-80 and >80 mg/L were 2.2, 2.3 and 2.4 nmol/g Hb respectively 164 
(p<0.001) with an overall elevation of 9%.  The median concentrations of red cell vitamin B2 165 
grouped according to albumin concentrations ≥35, 25-34 and <25 g/l were 2.1, 2.4 and 2.3 166 
nmol/g Hb respectively (p<0.001). 167 
When albumin concentrations were ≥ 35 g/L, the median red cell concentrations of 168 
vitamin B2 grouped according to CRP concentrations ≤10 and 11-80 were 2.1 and 2.2 nmol/g 169 
Hb respectively (p=0.147) with an overall elevation of 4%.  When albumin concentrations 170 
were 25-34 g/L, the median red cell concentrations of vitamin B2 grouped according to CRP 171 
concentrations ≤10 and 11-80 mg/L were 2.4 and 2.4 nmol/g Hb respectively (p=0.265). 172 
When albumin concentrations were < 25 g/L, the median red cell concentrations of vitamin 173 
B2 grouped according to CRP concentrations ≤10, 11-80 and >80 mg/L were 2.5, 2.3 and 2.5 174 
nmol/g Hb respectively (p=0.334).  Median red cell concentrations of vitamin B2/ albumin 175 
x100 were significantly increased from 6 to 8 to 14 respectively (p<0.001). 176 
1.3.3. Nutritional screen cohort for red cell vitamin B6 177 
The median concentrations of red cell vitamin B6 (Table 4) grouped according to 178 
CRP concentrations ≤10, 11-80 and >80 mg/L were 534, 548 and 767 pmol/g Hb respectively 179 
(p<0.001) with an overall elevation of 9%.  The median red cell concentrations of vitamin B2 180 
grouped according to albumin concentrations ≥35, 25-34 and <25 g/l were 462, 644 and 840 181 
pmol/g Hb respectively (p<0.001). 182 
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When albumin concentrations were ≥ 35 g/L, the median red cell concentrations of 183 
vitamin B6 grouped according to CRP concentrations ≤10 and 11-80 were 478 and 413 184 
pmol/g Hb respectively were not significantly different (p=0.286).  When albumin 185 
concentrations were 25-34 g/L, the median red cell concentrations of vitamin B6 grouped 186 
according to CRP concentrations ≤10 and 11-80 mg/L were 818, 547 and 669 pmol/g Hb 187 
respectively (p=0.056).  When albumin concentrations were < 25 g/L, the median red cell 188 
concentrations of vitamin B6 grouped according to CRP concentrations ≤10, 11-80 and >80 189 
mg/L were 1037, 822 and 81 pmol/g Hb respectively (p=0.802).  Median red cell 190 
concentrations of vitamin B6/ albumin x100 were significantly increased from 1380 to 2030 191 
to 3560 respectively (p<0.001). 192 
1.3.4. Nutritional screen cohort for plasma ascorbic acid. 193 
The median plasma concentrations of ascorbic acid (Table 5) grouped according to 194 
CRP concentrations ≤10, 11-80 and >80 mg/L were 25.0, 15.0 and 6.0 µmol/l respectively 195 
(p<0.001) with an overall reduction of 78%.  The median plasma concentrations of ascorbic 196 
acid grouped according to albumin concentrations ≥35, 25-34 and <25 g/l were 32.0, 13.0 and 197 
5.0 µmol/l respectively (p<0.001) with an overall reduction of 84%. 198 
When albumin concentrations were ≥ 35 g/L, the median plasma concentrations of 199 
ascorbic acid grouped according to CRP concentrations ≤10, 11-80 and >80 mg/L were 33.0, 200 
30 and 31µmol/l (p=0.765).  When albumin concentrations were 25-34 g/L, the median 201 
plasma concentrations of ascorbic acid grouped according to CRP concentrations ≤10, 11-80 202 
and >80 mg/L were 12.0, 15 and 10.0 µmol/l (p=0.409) with an overall reduction of 17%.  203 
When albumin concentrations were < 25 g/L, the median plasma concentrations of ascorbic 204 
acid grouped according to CRP concentrations ≤10, 11-80 and >80 mg/L were 3, 10 and 5.0 205 
µmol/l (p=0.121).  The median vitamin C/albumin ration x 100 for CRP concentrations ≤10, 206 
11-80 and >80 mg/L were 71.8, 53. 5 and 37.3 respectively (48%, p=0.050).  The median 207 
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vitamin C /CRP x 100 for albumin concentrations ≥35, 25-34 and <25 g/l were 711.5, 65.8 208 
and 10.3 (99%, p<0.001). 209 
1.3.5. Nutritional screen cohort for α-tocopherol / cholesterol  210 
The median α-tocopherol/ cholesterol (Table 6) grouped according to CRP 211 
concentrations ≤10, 11-80 and >80 mg/L were 5.9, 4.6 and 2.1 umol/l respectively (p<0.001) 212 
with an overall reduction of 64%.  The median α-tocopherol/cholesterol grouped according to 213 
albumin concentrations ≥35, 25-34 and <25 g/l were 6.0, 5.5 and 2.1 umol/l respectively 214 
(p<0.001) with an overall reduction of 65%. 215 
When albumin concentrations were ≥ 35 g/L, the median α-tocopherol/cholesterol 216 
grouped according to CRP concentrations ≤10 and 11-80 mg/L were 6.2 and 5.4 (p=0.134).  217 
When albumin concentrations were 25-34 g/L, the median α-tocopherol/cholesterol grouped 218 
according to CRP concentrations ≤10, 11-80 and >80 mg/L were 5.2, 6.0 and 4.6 (p=0.518) 219 
with an overall reduction of 12%.  When albumin concentrations were < 25 g/L, The median 220 
α-tocopherol/cholesterol grouped according to CRP concentrations ≤10, 11-80 and >80 mg/L 221 
were 3.8, 2.4 and 1.7 (p=0.032) with an overall reduction of 55%.222 
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1.4. Discussion  223 
The results of the present study show that red cell concentrations of vitamin B1, B2 224 
and B6 were not lower with an increasing magnitude of the systemic inflammatory response 225 
(as evidenced by both CRP and albumin concentrations).  Indeed, there was a relatively small 226 
but significant increase in red cell B1, B2 and B6 concentrations.  In contrast, plasma 227 
measurements of vitamin C and E were lower with an increasing magnitude of the systemic 228 
inflammatory response with the potential for misclassification of deficiency.  Therefore, red 229 
cell measurements appear to obviate the potential for misclassification of vitamin B1, B2 and 230 
B6 deficiency in the presence of systemic inflammatory response.  On this basis red cell 231 
measurements are recommended for the routine assessment of B-vitamin status.  232 
The present relationship between the systemic inflammatory response and low plasma 233 
vitamin C and E results are consistent with that previously reported for vitamins A, D and 234 
carotenoids.  Taken together these results would suggest that the systemic inflammatory 235 
response is associated with a redistribution of plasma vitamins, perhaps to specific tissues and 236 
organs irrespective of vitamin status.  Despite this strong and consistent association 237 
recognition of this phenomenon remains limited and plasma measurements of vitamins 238 
continue to be used to assess status.  Therefore, in order to obviate such interpretative 239 
problems it is essential that plasma vitamin measurements are accompanied by a measure of 240 
the systemic inflammatory response such as CRP and albumin.  Alternatively, that new 241 
methods of measurements are developed for the assessment of vitamins A, C, D, E and the 242 
carotenoids, that better reflect nutritional statuse. 243 
The results of the present study are particularly pertinent to plasma vitamin 244 
measurements carried out in patients with critical illness since almost all patients will have 245 
evidence of a systemic inflammatory response and may have a true deficiency and a need for 246 
supplementation.  This may explain the mixed results of vitamin supplementation in the 247 
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critically ill [14].  In contrast, measurements of thiamine,  FAD and PLP concentrations in 248 
blood may be considered to more reliably reflect nutritional status of vitamin B1, B2 and B6 249 
[1-4] and more reliably benefit from supplementation [14]. 250 
Vitamin C and E status is usually assessed by plasma measurement of α-tocopherol 251 
and ascorbic acid respectively, although their correlation with concentrations in tissues is not 252 
clearly established.  Moreover, plasma concentrations of vitamin E are strongly associated 253 
with their carrier lipids, principally lipoprotein complexes, such as high density lipoprotein 254 
(HDL), very low density lipoprotein (VLDL) and chylomicrons.  To overcome this limitation 255 
it has been proposed that the plasma α-tocopherol concentrations should be expressed in 256 
relation to plasma lipid concentrations, usually cholesterol [15-17].  In particular, the results 257 
of the present study question the use of the α-tocopherol adjusted for cholesterol to 258 
compensate for the effect of the systemic inflammatory response. Since, when expressed per 259 
mmol of cholesterol, α-tocopherol, concentrations were lower with decreasing concentrations 260 
of albumin. 261 
The role of vitamin C in alleviating the oxidant stress and recycling the oxidized α-262 
tocopherol is well recognised.  Plasma α-tocopherol concentrations, in addition to being 263 
redistributed as part of the systemic inflammatory response, have been reported to be 264 
regenerated by vitamin C.  Early work on fat autoxidation performed by Golumbic and 265 
Mattill (1941) reported the antioxygenic action of ascorbate in association with tocopherols 266 
[18].  More recently, in vitro studies have shown that ascorbic acid reduces the tocopheroxyl 267 
radical [19] and thereby restores the radical-scavenging activity of tocopherol [20-24].  It 268 
would appear that the tocopheroxyl radical that forms in membranes reacts with ascorbic acid 269 
to yield tocopherol and the ascorbyl radical, the result of which is to maintain radical 270 
scavenging potential within the membrane by regenerating tocopherol and to transfer the 271 
oxidative challenge to the aqueous phase.  This scheme is consistent with the observation in 272 
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the present study that plasma vitamin C concentrations were lower compared with vitamin E 273 
concentrations for the same magnitude of the systemic inflammatory response and even in 274 
patients with critical illness in whom vitamin C concentrations were recognised to be 275 
profoundly low [25-27]. 276 
The importance of the systemic inflammatory response in determining plasma vitamin 277 
C concentrations is highlighted by the relative inefficiency, whereby supplementation can 278 
prevent low concentrations following an inflammatory insult.  For example, in healthy 279 
patients with normal pre–operative plasma concentrations of ascorbic acid, a single oral 280 
supplementation with 1,000 mg of ascorbic acid was unable to prevent the fall in 281 
postoperative plasma concentrations [28].  Therefore, it is reasonable to conclude that 282 
ascorbic acid deficiency and the need for supplementation should only be considered on the 283 
basis of low plasma ascorbic acid concentrations in the presence of plasma CRP and albumin 284 
concentrations in the normal range. 285 
The present study has a number of limitations.  In particular there was no information 286 
on the presence of chronic disease, co-morbidity or on BMI and dietary intake.  Nevertheless, 287 
it is likely that the impact of these clinical factors on vitamins B1, B2, B6 C and E will 288 
involve the systemic inflammatory response, at least in part. 289 
In summary, the results of the present study show that, unlike plasma concentrations 290 
of vitamins C and E, red cell concentrations of vitamin B1, B2 and B6 were not significantly 291 
affected by the systemic inflammatory response.  Therefore, red cell B1, B2 and B6 292 
concentrations are likely to be a more reliable measure of status in patients with evidence of a 293 
systemic inflammatory response294 
  
15 
 
Acknowledgement 295 
The authors acknowledge the Libyan government for funding.  296 
The authors gratefully acknowledge the assistance of Denis O’Reilly, Andrew 297 
Duncan, Pamela Moyes, Karen Elliot, Allison McLaughlin, Lesley Stuart and Isobel Hogg, 298 
Scottish Reference Laboratory for Vitamins and Trace Elements, Glasgow Royal Infirmary. 299 
Declaration 300 
The authors confirm that there are no conflicts of interest. 301 
Authors’ statements  302 
DCM, JK and DT conceived the idea of examining the relationship between red cell vitamin 303 
B1, B2 and B6, CRP and albumin concentrations in a large cohort and in patients with critical 304 
illness and funded the study.  RAG and DCM performed the statistical analysis.  All authors 305 
contributed to the drafts and final version of the paper and are the guarantors.306 
  
16 
 
Reference List 307 
 308 
 [1]  Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O'Reilly DS. 309 
Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic 310 
inflammatory response. Clinical Chemistry 2003; 49: 515-518. 311 
 [2]  Quasim T, McMillan DC, Talwar D, Vasilaki A, O'Reilly DSJ, Kinsella J. The 312 
relationship between plasma and red cell B-vitamin concentrations in critically-ill 313 
patients. Clinical Nutrition 2005; 24: 956-960. 314 
 [3]  Duncan A, Talwar D, McMillan DC, Stefanowicz F, O'Reilly DS. Quantitative data 315 
on the magnitude of the systemic inflammatory response and its effect on 316 
micronutrient status based on plasma measurements. American Journal of Clinical 317 
Nutrition 2012; 95: 64-71. 318 
 [4]  Gray A, McMillan DC, Wilson C, Williamson C, O'Reilly DSJ, Talwar D. The 319 
relationship between plasma and red cell concentrations of vitamins thiamine 320 
diphosphate, flavin adenine dinucleotide and pyridoxal 5-phosphate following 321 
elective knee arthroplasty. Clinical Nutrition 2004; 23: 1080-1083. 322 
 [5]  Ghashut A, McMillan D, Kinsella J, Duncan A, Talwar D. Quantitative data on the 323 
magnitude of the systemic inflammatory response and its effect on carotenoids status 324 
based on plasma measurements. Journal of clinical nutrition 2013; 8: e193-e199. 325 
 [6]  Ghashut RA, Talwar D, Kinsella J, Duncan A, McMillan DC. The effect of the 326 
systemic inflammatory response on plasma vitamin 25 (OH) D concentrations 327 
adjusted for albumin. Plos One 2014; 9: e92614. 328 
 [7]  Ghashut RA, McMillan DC, Kinsella J, Vasilaki AT, Talwar D, Duncan A. The effect 329 
of the systemic inflammatory response on plasma zinc and selenium adjusted for 330 
albumin. Clinical Nutrition 2016; 35: 381-388. 331 
 [8]  Stefanowicz F, Gashut RA, Talwar D, Duncan A, Beulshausen JF, McMillan DC, 332 
Kinsella J. Assessment of plasma and red cell trace element concentration, disease 333 
severity, and outcome in patients with critical illness. Journal of Critical Care 2013; 1-334 
5. 335 
 [9]  Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O'Reilly DS. 336 
Optimisation and validation of a sensitive high-performance liquid chromatography 337 
assay for routine measurement of pyridoxal 5-phosphate in human plasma and red 338 
cells using pre-column semicarbazide derivatisation. Journal of Chromatography B-339 
Analytical Technologies in the Biomedical and Life Sciences 2003; 792: 333-343. 340 
 [10]  Margolis SA, Davis TP. Stabilization of Ascorbic-Acid in Human-Plasma, and Its 341 
Liquid-Chromatographic Measurement. Clinical Chemistry 1988; 34: 2217-2223. 342 
  
17 
 
 [11]  Talwar D, Ha TKK, Cooney J, Brownlee C, SO'Reilly D. A routine method for the 343 
simultaneous measurement of retinol, alpha-tocopherol and five carotenoids in human 344 
plasma by reverse phase HPLC. Clinica Chimica Acta 1998; 270: 85-100. 345 
 [12]  Marsik C, Kazemi-Shirazi L, Schickbauer T, Winkler S, Joukhadar C, Wagner O, 346 
Endler G. C-Reactive Protein and All-Cause Mortality in a Large Hoepital-Based 347 
Cohort. Clinical Chemistry 2008; 54: 343-349. 348 
 [13]  Goldwasser P, Feldman J. Association of serum albumin and mortality risk. Journal of 349 
Clinical Epidemiology 1997; 50: 693-703. 350 
 [14]  Berger M. Micronutrients. In: Preiser J (ed.), The stress response of critical illness: 351 
Metabolic and hormonal aspects. Springer International Publishing Switzerland 2016; 352 
2016: 107-122. 353 
 [15]  Vasilaki AT, Leivaditi D, Talwar D, Kinsella J, Duncan A, O'Reilly DS, McMillan 354 
DC. Assessment of vitamin E status in patients with systemic inflammatory response 355 
syndrome: Plasma, plasma corrected for lipids or red blood cell measurements? 356 
Clinica Chimica Acta 2009; 409: 41-45. 357 
 [16]  Doise C, Aho LS, Quenot JP, Guilland JC, Zeller M, Vergely C, Aude H, Blettery B, 358 
Rochette L. Plasma antioxidant status in septic critically ill patients: a decrease over 359 
time. Fundamental &Clinical Pharmacology 2008; 22: 203-209. 360 
 [17]  Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different 361 
lipids to express serum tocopherol-Lipid ratios for the measurment of vitamin E 362 
status. Annals of Clinical Biochemistry 1986; 23: 514-520. 363 
 [18]  Golumbic C, Mattill H. Antioxidants and the Autoxidation of Fats. XIII. 364 
Antioxygenic Action of Ascorbic Acid in Association with Tocopherols, 365 
Hydroquinones and Related Compounds. Journal of the american chemical society 366 
1941; 63: 1279-1280. 367 
 [19]  Packer JE, Slater TF, Willson RL. Direct observation of a free redical interaction 368 
between vitamin E and vitamin C. Nature 1979; 278: 737-738. 369 
 [20]  Doba T, Burton GW, Ingold KU. Antioxidant and cooxidant activity of vitamin C-370 
The effect of vitamin C either alone, or in the presence of vitamin E or a water soluble 371 
vitamin E analog, upon of peroxidation of aqueous multilamellar phospholipid 372 
liposomes. Biochimica et Biophysica Acta 1985; 835: 298-303. 373 
 [21]  Lambelet P, Saucy F, Lölliger J. Chemical evidence for interactions between vitamin 374 
E and vitamin C. Experientia 1985; 41: 1384-1388. 375 
 [22]  Niki E, Tsuchiya J, Tanimura R, Kamiya Y. Regeneration of vitamin E from á-376 
chromanoxyl radical by glutathione and vitamin C. Chemistry Letters 1982; 11: 789-377 
792. 378 
 [23]  Niki E. Interaction of ascorbate and átocopherol. Annals of the New York Academy 379 
of sciences 1987; 498: 186-199. 380 
  
18 
 
 [24]  Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke S.J. The relative 381 
contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical 382 
trapping activity of human blood plasma. Biochimica et Biophysica Acta 1987; 924: 383 
408-419. 384 
 [25]  Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, 385 
Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in 386 
critically ill surgical patients. Annals of Surgery 2002; 236: 814-822. 387 
 [26]  Mishra V, Baines M, Wenstone R, Shenkin A. Markers of oxidative damage, 388 
antioxidant status and clinical outcome in critically ill patients. Annals of Clinical 389 
Biochemistry 2005; 42: 269-276. 390 
 [27]  Schorah C, Downing C, Piriptsi A, Gallivan L, AL-Hazaa A, Sanderson M, 391 
Bodenham A. Total vitamin C, ascorbic acid, and dehydroascorbic acid 392 
concentrations in plasma of critically ill patients. American Journal of Clinical 393 
Nutrition 1996; 63: 760-765. 394 
 [28]  Ruemelin A, Doerr S, Fauth U. Single preoperative oral application of ascorbic acid 395 
does not affect postoperative plasma levels of ascorbic acid. Annals of Nutrition and 396 
Metabolism 2002; 46: 211-214. 397 
 398 
399 
  
19 
 
 
Tables legends 
Table 1. Characteristics of nutritional screen cohorts with measurements of vitamins B1, B2, B6, C and E concentrations. 
Table 2.  Distribution of whole blood vitamin B1 (ng/g Hb) according to C-reactive protein and albumin concentrations (n=553). 
Table 3.  Distribution of red cell vitamin B2 according to C-reactive protein and albumin concentrations (n=251). 
Table 4.  Distribution of red cell vitamin B6 (pmol/g Hb) according to C-reactive protein and albumin concentrations (n=312). 
Table 5:  Distribution of plasma vitamin C (ascorbic acid) (µmol/l) according to CRP and albumin concentrations (n=494). 
Table 6:  Distribution of plasma α-tocopherol adjusted to cholesterol according to CRP and albumin concentrations (n=359).
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Figure legends 
Figure 1a.The relationship between CRP (log 10) and whole blood vitamin B1 (ng/g Hb) (rs= 0.290, p<0.001) ). 
Figure 1b.The relationship between albumin and whole blood vitamin B1 (nmol/l) (rs= - 0.265, p<0.001). 
Figure 1c.The relationship between vitamin B1 adjusted for albumin and CRP (rs= 0.583, p<0.001)  
Figure 2a.The relationship between CRP (log 10) and red cells vitamin B2 (nmol/g Hb) (rs= 0.189, p=0.003). 
Figure 2b.The relationship between albumin and red cells vitamin B2 (nmol/g Hb) (rs=  0.186, p<0.001). 
Figure 2c.The relationship between vitamin B2 adjusted for albumin and CRP (rs= 0.543, p<0.001). 
Figure 3a.The relationship between CRP (log 10) and red cells vitamin B6 (pmol/g Hb) (rs= 0.079, p=0.161) 
Figure 3b.The relationship between albumin and red cells vitamin B6 (pmol/g Hb) (rs= - 0.217, p<0.001) 
Figure 3c.The relationship between vitamin B6 adjusted to albumin and CRP (rs= 0.238, p<0.001) 4a:  The relationship between CRP (log 10) 
and vitamin C (µmol/l) (rs= - 0.333, p<0.001)  
Figure 4b:  The relationship between albumin and vitamin C (µmol/l) (rs= 0.427, p<0.001). 
Figure 4c:  The relationship between CRP (log 10) and vitamin C adjusted to albumin (rs= - 0.179, p<0.001). 
Figure 5a:  The relationship between α-tocopherol adjusted to cholesterol and CRP (log 10) (rs= - 0.424, p<0.001)  
Figure 5b:  The relationship between α-tocopherol adjusted to cholesterol and albumin (rs=  0.531, p<0.001). 
Figure 5c:  The relationship between CRP (log 10) and vitamin α-tocopherol adjusted to cholesterol and albumin (rs= - 0.094, p= 0.359). 
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Table 1. Characteristics of nutritional screen cohorts with measurements of vitamins B1, B2, B6, C and E concentrations. 
 Reference 
interval 
Nutritional screen 
cohort Whole blood 
vitamin B1 (n=553) 
Nutritional screen 
cohort Vitamin B2 
 (n=251) 
Nutritional screen 
cohort Vitamin B6 
 (n=313) 
Nutritional 
screen cohort 
Vitamin C 
(n=494) 
Nutritional 
screen cohort 
Vitamin E  
(n=359) 
Age (years) NA 54 (18-100) 51 (16-82) 51 (16-82) 54 (16-90) 52 (15-100) 
Sex (Male/Female) NA 276 (50%)/ 277 
(50%) 
111 (44%)/ 140 
(56%) 
125 (40%)/ 188 
 (60%) 
234 (47%)/ 260 
(53%) 
185 (52%)/ 174 
(48%) 
C-reactive protein (mg/l) <10 14.0 (<10- 565.0) 5.0 (<10- 565.0) 4.3 (<10- 301.0) 10.0 (0.20- 565.0) 9.0 (0.20- 565.0) 
Albumin (g/l) 35-55 32 (6-50) 36 (9-49) 35 (9-49) 33 (9-50) 31 (9-50) 
B1 (ng/g Hb) 275- 675 613 (175-3650)     
B2 (nmol/g Hb) 1.0 – 3.4  2.2 (1.2-27.3)    
B6 (pmol/g Hb) 250 – 680    540 (79-100755)   
Plasma ascorbic acid 11-114    17.0 (0.9-262.0)  
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(µmol/l) 
Plasma α-tocopherol 
(umol/l) 
12 - 46     21.0 (2.9-58.0) 
Cholesterol (mmol/l) <5.2     4.5 (1.1-15.7) 
α-tocopherol/ cholesterol 
ratio 
(μmol/ mmol) 
5.2 (3.5-
8.7)  
    5.2 (0.4-19.5) 
(Median and range)
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Table 2.  Distribution of whole blood vitamin B1 (ng/g Hb) according to C-reactive protein and albumin concentrations (n=553). 
whole blood vitamin B1 
(ng/g Hb) 
CRP ≤10 (mg/l) 11-80 (mg/l) >80 (mg/l) whole blood vitamin B1 
according to albumin 
Albumin ≥35 (g/l) 535 (211-2067) 
(n=175) 
619 (201-1508) 
(n=61) 
 
(n=2) 
547 (201-2067) 
(n=238)  
34-25 (g/l) 611 (175-1781) 
(n=56) 
693 (260-2552) 
(n=77) 
776 (385-3650) 
 (n=18) 
664 (175-3650) 
(n=151)  
<25 (g/l) 574 (233-1248) 
(n=19) 
671 (288-2129) 
(n=71) 
745 (196-3524) 
(n=74) 
701 (196-3524) 
(n=164)  
whole blood vitamin B1 
according to CRP 
543 (175-2067) 
(n=250)  
664 (201-2552) 
(n=209)  
766 (196-3650) 
(n=94)  
 
Median (range), where n<10 median and range not calculated. 
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Table 3.  Distribution of red cell vitamin B2 according to C-reactive protein and albumin concentrations (n=251). 
Red cell B2 (nmol/g Hb CRP ≤10 (mg/l) 11-80 (mg/l) >80 (mg/l) Red cell B2  
according to albumin 
Albumin ≥35 (g/l) 2.1 (1.2-5.9) 
(n=121) 
2.2 (1.9-3.1) 
(n=15) 
- 
(n=0) 
2.1 (1.2-5.9) 
(n=136)  
34-25 (g/l) 2.4 (1.2-27.3) 
(n=38) 
2.4 (1.6-5.8) 
(n=38) 
- 
 (n=1) 
2.4 (1.2-27.3) 
(n=77)  
<25 (g/l)  
(n=6) 
2.3 (1.3-3.5) 
(n=21) 
2.5 (2.0-5.5) 
(n=11) 
2.3 (1.3-5.5) 
(n=38)  
Red cell B2 
according to CRP 
2.2 (1.2-27.3) 
(n=165)  
2.3 (1.3-57.8) 
(n=74)  
2.4 (1.6-5.5) 
(n=12)  
 
Median (range), where n<10 median and range not calculated.
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Table 4.  Distribution of red cell vitamin B6 (pmol/g Hb) according to C-reactive protein and albumin concentrations (n=312). 
Red cells B6 (pmol/g Hb) CRP ≤10 (mg/l) 11-80 (mg/l) >80 (mg/l) Red cells B6  
according to albumin 
Albumin ≥35 (g/l) 478 (138-72374) 
(n=155) 
413 (181-2812) 
(n=18) 
- 
(n=0) 
462 (138-72374) 
(n=173)  
34-25 (g/l) 818 (79-61870) 
(n=47) 
547 (164-9245) 
(n=42) 
 
 (n=2) 
644 (79-61870) 
(n=91)  
<25 (g/l) 1037 (206-3036) 
(n=12) 
822 (183-100755) 
(n=24) 
881 (291-23294) 
(n=12) 
840 (183-100755) 
(n=48)  
Red cells B6 
according to CRP 
534 (79-27374) 
(n=214)  
548 (164-100775) 
(n=85)  
767 (291-23294) 
(n=14)  
 
Median (range), where n<10 median and range not calculated 
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Table 5:  Distribution of plasma vitamin C (ascorbic acid) (µmol/l) according to CRP and albumin concentrations (n=494). 
Plasma vitamin C 
(ascorbic acid) (µmol/l) 
CRP ≤10 (mg/l) 11-80 (mg/l) >80 (mg/l) Plasma C (ascorbic acid) 
according to albumin 
Albumin ≥35 (g/l) 33 (0.99-235) 
(n=175) 
30 (0.99-79.0) 
(n=44) 
31 (17.0-66.0) 
(n=4) 
32 (0.99-235) 
(n=223)  
34-25 (g/l) 12 (0.90-126) 
(n=61) 
15 (0.99-136) 
(n=66) 
10 (0.99-61.0) 
 (n=19) 
13 (0.90-136) 
(n=146)  
<25 (g/l) 3 (0.90-40.0) 
(n=12) 
10 (0.90-262) 
(n=50) 
5.0 (0.90-102.0) 
(n=63) 
5 (0.90-262) 
(n=125)  
Plasma C (ascorbic acid) 
according to CRP 
25 (0.90-235) 
(n=248)  
15 (0.90-262.0) 
(n=160)  
6.0 (0.90-102.0) 
(n=86)  
 
Median (range) (number of observation)  
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Table 6:  Distribution of plasma α-tocopherol adjusted to cholesterol according to CRP and albumin concentrations (n=359). 
Plasma α-tocopherol / 
cholesterol ratio 
CRP ≤10 (mg/l) 11-80 (mg/l) >80 (mg/l) Plasma α-tocopherol / 
cholesterol ratio 
 according to albumin 
Albumin ≥35 (g/l) 6.2 (3.2-10.7) 
(n=131) 
5.4 (3.3-10.8) 
(n=18) 
- 
(n=1) 
6.0 (3.2-10.8) 
(n=150)  
34-25 (g/l) 5.2 (0.97-10.4) 
(n=48) 
6.0 (1.2-9.7) 
(n=38) 
4.6 (1.3-8.3) 
 (n=12) 
5.5 (1.0-10.4) 
(n=98)  
<25 (g/l) 3.8 (1.1-7.6) 
(n=15) 
2.4 (0.9-17.0) 
(n=31) 
1.7 (0.4-19.4) 
(n=65) 
2.1 (0.4-19.5) 
(n=111)  
Plasma α-tocopherol / 
cholesterol ratio  
according to CRP 
5.9 (1.0-10.7) 
(n=194)  
4.6 (0.9-17.0) 
(n=87)  
2.1 (0.4-19.5) 
(n=78)  
 
Median (range) (number of observation) 
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